Response to US review rules on patent subject matter of traditional Chinese medicine compositions / 中国中药杂志
China Journal of Chinese Materia Medica
;
(24): 627-630, 2018.
Artigo
em Chinês
| WPRIM
| ID: wpr-771691
ABSTRACT
The United States Patent and Trademark Office(USPTO) issued Interim Guidance on Patent Subject Matter Eligibility on December 16, 2014, bringing certain effects to the review rules on patent application of Chinese medicine compositions. Based on the Interim Guidance, cases analysis was used in this paper to analyze the patent subject matter issues of traditional Chinese medicine compositions in the United States. The researches have shown that the application documents should be properly written in the United States when the patent for Chinese medicine compositions is applied, which can improve the probability of authorization.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Patentes como Assunto
/
Padrões de Referência
/
Pesquisa
/
Estados Unidos
/
Medicamentos de Ervas Chinesas
/
Química
/
Medicina Tradicional Chinesa
Tipo de estudo:
Estudo diagnóstico
País/Região como assunto:
América do Norte
Idioma:
Chinês
Revista:
China Journal of Chinese Materia Medica
Ano de publicação:
2018
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS